These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 15920337)

  • 1. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
    Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
    Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of almotriptan in controlled clinical trials.
    Mathew NT
    Eur Neurol; 2005; 53 Suppl 1():29-33. PubMed ID: 15920335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
    Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
    Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.
    Stark S; Spierings EL; McNeal S; Putnam GP; Bolden-Watson CP; O'Quinn S
    Headache; 2000; 40(7):513-20. PubMed ID: 10940089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
    Dodick DW
    Headache; 2002 Jan; 42(1):21-7. PubMed ID: 12005271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
    Von S
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
    Colman SS; Brod MI; Krishnamurthy A; Rowland CR; Jirgens KJ; Gomez-Mancilla B
    Clin Ther; 2001 Jan; 23(1):127-45. PubMed ID: 11219473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.